Kestra Advisory Services’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.14M Buy
6,071
+4,142
+215% +$761K ﹤0.01% 1739
2026
Q1
$364K Sell
1,929
-436
-18% -$91.9K ﹤0.01% 2467
2025
Q4
$470K Buy
2,365
+975
+70% +$197K ﹤0.01% 2198
2025
Q3
$282K Sell
1,390
-80
-5% -$14.2K ﹤0.01% 2498
2025
Q2
$259K Buy
+1,470
New +$221K ﹤0.01% 2465
2024
Q3
Sell
-2,786
Closed -$371K 2736
2024
Q2
$371K Buy
+2,786
New +$335K ﹤0.01% 1985

Other funds holding THC

Kestra Advisory Services's THC Position: Q2 2026 in Review

Kestra Advisory Services increased its Tenet Healthcare (THC) stake by 215% in Q2 2026, buying an estimated $761K and bringing the position to 6,071 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #1739.

Kestra Advisory Services first reported a position in THC in Q2 2024 and has held it in 6 quarters since. 673 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Kestra Advisory Services held 6,071 shares of Tenet Healthcare worth $1.14M as of Q2 2026.
  • Kestra Advisory Services bought 4,142 Tenet Healthcare shares in Q2 2026, an estimated $761K.
  • Tenet Healthcare made up ﹤0.01% of Kestra Advisory Services's portfolio in Q2 2026, its #1739 holding.
  • Kestra Advisory Services first reported a position in Tenet Healthcare in Q2 2024 and has held it in 6 quarters since.
  • 673 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.